Rhinovirus diagnostics market seen reaching $2.33 billion by 2030

The rhinovirus diagnostics market is projected to grow from $1.71 billion in 2026 to $2.33 billion by 2030, according to The Business Research Company. The report points to rising respiratory infections, more point-of-care testing, and AI-enabled diagnostics as key drivers, with North America leading in 2025 and Asia-Pacific expected to grow fastest.

Why it matters: - Rhinovirus diagnostics are used to confirm infections that cause the common cold and help clinicians make faster treatment decisions. - The market growth reflects broader demand for more accurate respiratory testing as infections and respiratory disorders rise worldwide. - Better diagnostics can help reduce transmission, improve patient outcomes, and support earlier care decisions.

What happened: - The Business Research Company published a rhinovirus diagnostics market report on July 22, 2026. - The report projects the market will grow from $1.58 billion in 2025 to $1.71 billion in 2026. - The report forecasts the market will reach $2.33 billion by 2030. - The projected compound annual growth rate is 8.2% from 2026 to 2030.

The details: - Historical growth was driven by higher rates of common colds and respiratory infections, wider use of molecular diagnostic methods, improved hospital laboratory testing, limits of traditional virus culture techniques, and greater awareness of early infectious disease diagnosis. - Future growth is expected to come from demand for rapid point-of-care tests, AI-driven interpretation tools, multiplex testing panels, more infectious disease monitoring investment, and precision medicine approaches for respiratory conditions. - Emerging trends include AI-enhanced respiratory pathogen identification, broader use of multiplex PCR respiratory virus panels, point-of-care rhinovirus diagnostic devices, cloud-based infectious disease surveillance platforms, and highly sensitive molecular assays. - The report defines rhinovirus diagnostics as laboratory and clinical tests that detect and confirm rhinovirus infections using respiratory samples and molecular technologies. - These tests are positioned as tools for timely treatment choices and infection control. - An increasing prevalence of respiratory disorders is a major growth driver. - The report cites National Center for Biotechnology Information data from December 2023 projecting COPD cases to rise by 112 million to 592 million by 2050, equal to 9.5% of the eligible population. - Rising healthcare spending is another growth driver. - The Office for National Statistics reported in April 2025 that UK healthcare spending in 2024 reached about $29.88 billion (£317 billion), up 6.5% from 2023. - In 2025, North America held the largest market share. - Asia-Pacific is expected to grow the fastest during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The 2026 report edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated trend analysis. - A free sample report is available. - The full report is also available.

Between the lines: - The report points to a market moving from basic detection toward faster, more integrated respiratory testing. - AI, multiplex panels, and cloud-based surveillance suggest diagnostics are becoming part of broader infection-management systems, not just standalone lab tests. - The regional split suggests mature demand in North America and more room for expansion in Asia-Pacific.

What's next: - The market is expected to keep expanding through 2030 as rapid testing and multiplex respiratory panels spread. - New product development is likely to focus on speed, sensitivity, and digital interpretation. - Healthcare systems and testing providers will likely keep investing in diagnostic infrastructure as respiratory monitoring expands. - The Business Research Company is also promoting its Global Market Model and broader industry report library as planning tools for buyers and analysts.